Pavmed beats Q2 EPS by a penny

Medical device maker Pavmed Inc. (NSDQ:PAVM) topped expectations on Wall Street with its second quarter results today. The New York-based company posted a net loss of -$989,707, or -8¢ per share, for the 3 months ended June 30, for bottom-line growth of 25% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Pavmed beats Q2 EPS by a penny appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Drug-Device Combinations MassDevice Earnings Roundup Pharmaceuticals Vascular Wall Street Beat Pavmed Source Type: news